BIOMOL International - Ownership and Business Overview

Medical ProductsCompany

BIOMOL International Ownership

Who owns BIOMOL International?

BIOMOL International is owned by Enzo Biochem. It was acquired on May 9, 2008.

BIOMOL International Business Overview

Where is BIOMOL International headquartered?

BIOMOL International is headquartered in Plymouth Meeting, Pennsylvania.

What sector is BIOMOL International in?

BIOMOL International is a medical products company.

When was BIOMOL International founded?

BIOMOL International was founded in 1983.

Medical Products M&A Summary in 2008

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2008. The largest medical products acquisition in 2008 was Barr Pharmaceuticals - which was acquired by Teva Pharmaceutical Industries for $7.5B.

Join Mergr to view all 119 acquisitions of medical products companies in 2008, including 35 acquisitions by private equity firms, and 84 by strategics.

BIOMOL International, LP

5120 Butler Pike,
Plymouth Meeting, Pennsylvania 19462
United States,
(610) 941-0430

BIOMOL International, LP is a privately owned global producer of over 3,300 specialty life science products for the areas of signal transduction, lipid research, apoptosis, neuroscience and drug discovery, with a research focus in the field of functional proteomics.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.